Skip to main content
logo
Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
14.15
+0.07 (0.50%)
At close: Aug 26, 2026, 4:00 PM EDT
14.15
0.00 (0.00%)
After-hours: Aug 26, 2026, 7:30 PM EDT

Enanta Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Market Capitalization
4122562202351,0751,148
Market Cap Growth
122.65%16.57%-6.67%-78.12%-6.39%24.98%
Enterprise Value
38325917373809784
Last Close Price
14.1511.9710.3611.1751.8756.81

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Forward PE
-6.266.266.266.26105.09
PS Ratio
6.323.923.252.9712.4811.83
PB Ratio
4.083.951.701.093.352.88
P/TBV Ratio
4.083.951.701.093.352.88
PEG Ratio
-1.821.821.821.821.82

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
EV/Sales Ratio
5.863.962.560.939.398.08

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Debt / Equity Ratio
1.803.111.761.030.080.02
Net Debt / Equity Ratio
-0.290.19-0.17-0.68-0.78-0.86
Net Debt / EBITDA Ratio
0.55-0.150.191.092.083.25
Net Debt / FCF Ratio
0.80-0.380.231.312.904.89
Asset Turnover
0.220.200.160.190.210.21
Quick Ratio
3.624.034.996.5210.008.43
Current Ratio
3.764.215.216.7310.458.82
Return on Equity (ROE)
-70.12%-84.63%-67.16%-49.74%-33.78%-18.48%
Return on Assets (ROA)
-12.28%-16.23%-18.13%-20.47%-19.01%-14.81%
Return on Invested Capital (ROIC)
-50.40%-92.97%-138.32%-163.29%-94.88%-91.02%
Return on Capital Employed (ROCE)
-24.20%-36.80%-38.10%-34.30%-35.80%-27.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Earnings Yield
-15.34%-32.00%-52.86%-56.90%-11.33%-6.88%
FCF Yield
-8.96%-12.57%-44.06%-47.71%-8.08%-6.16%
Buyback Yield / Dilution
-27.12%-0.85%-0.90%-1.78%-2.14%-1.16%
SEC Filings: 10-K · 10-Q